Get the Stockscreener App
4.86
2.10%
0.10
After Hours:
4.80
-0.06
-1.23%
Goodrx Holdings Inc stock is traded at $4.86, with a volume of 681.54K.
It is up +2.10% in the last 24 hours and down -21.74% over the past month.
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
See More
Previous Close:
$4.76
Open:
$4.79
24h Volume:
681.54K
Relative Volume:
0.50
Market Cap:
$1.84B
Revenue:
$775.09M
Net Income/Loss:
$-58.68M
P/E Ratio:
192.86
EPS:
0.0252
Net Cash Flow:
$64.06M
1W Performance:
+12.76%
1M Performance:
-21.74%
6M Performance:
-31.93%
1Y Performance:
-16.49%
1-Day Range:
$4.7764
$4.885
1-Week Range:
$4.185
$5.05
52-Week Range:
$4.09
$9.2599
Goodrx Holdings Inc Stock (GDRX) Company Profile
Name
Goodrx Holdings Inc
Sector
Industry
Phone
(855) 268-2822
Address
2701 OLYMPIC BOULEVARD, SANTA MONICA
Compare GDRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GDRX
Goodrx Holdings Inc
|
4.86 | 1.84B | 775.09M | -58.68M | 64.06M | 0.0252 |
|
VEEV
Veeva Systems Inc
|
226.76 | 36.93B | 2.57B | 615.26M | 996.76M | 3.32 |
|
SOLV
Solventum Corp
|
72.48 | 12.43B | 8.26B | 66.00M | 1.17B | 0.00 |
|
TEM
Tempus Ai Inc
|
62.98 | 10.01B | 640.44M | -743.28M | -206.93M | 0.00 |
|
DOCS
Doximity Inc
|
53.39 | 9.94B | 493.63M | 160.55M | 162.20M | 0.55 |
|
HQY
Healthequity Inc
|
102.47 | 8.91B | 1.10B | 105.67M | -197.98M | 0.1475 |
Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-09-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| May-23-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| May-16-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Apr-10-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-25-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-01-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-02-24 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-10-23 | Upgrade | DA Davidson | Neutral → Buy |
| Jul-31-23 | Upgrade | TD Cowen | Market Perform → Outperform |
| Dec-01-22 | Initiated | Citigroup | Buy |
| Nov-04-22 | Upgrade | JP Morgan | Underweight → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-12-22 | Initiated | DA Davidson | Neutral |
| Jun-10-22 | Downgrade | Goldman | Buy → Neutral |
| Jun-06-22 | Resumed | BofA Securities | Buy |
| Jun-01-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-10-22 | Downgrade | Evercore ISI | Outperform → In-line |
| May-10-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| May-10-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-10-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-11-22 | Initiated | Wells Fargo | Equal Weight |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Neutral |
| Mar-15-22 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-01-22 | Reiterated | Barclays | Overweight |
| Mar-01-22 | Reiterated | BofA Securities | Neutral |
| Mar-01-22 | Downgrade | Cowen | Outperform → Market Perform |
| Mar-01-22 | Downgrade | Credit Suisse | Outperform → Neutral |
| Mar-01-22 | Reiterated | Evercore ISI | Outperform |
| Mar-01-22 | Reiterated | Goldman | Buy |
| Mar-01-22 | Reiterated | JP Morgan | Underweight |
| Mar-01-22 | Reiterated | RBC Capital Mkts | Outperform |
| Mar-01-22 | Reiterated | SVB Leerink | Outperform |
| Jan-07-22 | Initiated | Goldman | Buy |
| Dec-21-21 | Initiated | Stephens | Overweight |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Aug-31-21 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-13-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-28-21 | Initiated | Robert W. Baird | Neutral |
| Apr-06-21 | Resumed | Evercore ISI | Outperform |
| Jan-25-21 | Initiated | Guggenheim | Buy |
| Nov-19-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-18-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-19-20 | Initiated | Barclays | Equal Weight |
| Oct-19-20 | Initiated | BofA Securities | Neutral |
| Oct-19-20 | Initiated | Citigroup | Buy |
| Oct-19-20 | Initiated | Cowen | Outperform |
| Oct-19-20 | Initiated | Credit Suisse | Outperform |
| Oct-19-20 | Initiated | Deutsche Bank | Hold |
| Oct-19-20 | Initiated | Goldman | Neutral |
| Oct-19-20 | Initiated | JP Morgan | Neutral |
| Oct-19-20 | Initiated | Morgan Stanley | Overweight |
| Oct-19-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-19-20 | Initiated | SVB Leerink | Outperform |
| Oct-19-20 | Initiated | UBS | Buy |
View All
Goodrx Holdings Inc Stock (GDRX) Latest News
Rubric Capital Management LP Has $32.48 Million Holdings in GoodRx Holdings, Inc. (NASDAQ:GDRX) - MarketBeat
GoodRx Holdings, Inc. (NASDAQ:GDRX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Class Action Filed Against GoodRx Holdings, Inc. (GDRX) Seeking Recovery for InvestorsContact Levi & Korsinsky - GuruFocus.com
US Penny Stocks To Consider In November 2024 - Simply Wall St
GoodRx (NASDAQ:GDRX) Trading Up 8.2%Time to Buy? - MarketBeat
GoodRx Holdings, Inc. (NASDAQ:GDRX) Shares Sold by Connor Clark & Lunn Investment Management Ltd. - MarketBeat
Why GoodRx Holdings Stock Was Sinking This Week - MSN
GoodRx Holdings, Inc. (GDRX) Misses Q3 Earnings and Revenue Estimates - MSN
GoodRx (NASDAQ:GDRX) Sees Large Volume IncreaseWhat's Next? - MarketBeat
GoodRx (NASDAQ:GDRX) Shares Down 7.5%Here's Why - MarketBeat
AMERIPRISE FINANCIAL INC's Strategic Reduction in GoodRx Holdings Inc - GuruFocus.com
Rubric Capital Management LP's Strategic Acquisition in GoodRx H - GuruFocus.com
GoodRx stock hits 52-week low at $4.66 amid market challenges - Investing.com India
Kuehn Law Encourages Investors of GoodRx Holdings, Inc. to Contact Law Firm - PR Newswire
GOODRX ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Barclays Has Lowered Expectations for GoodRx (NASDAQ:GDRX) Stock Price - MarketBeat
GoodRx Holdings Third Quarter 2024 Earnings: EPS Misses Expectations - Yahoo Finance
Reviewing TELUS International (Cda) (NYSE:TIXT) & GoodRx (NASDAQ:GDRX) - Defense World
GoodRx Holdings, Inc. (NASDAQ:GDRX) Q3 2024 Earnings Call Transcript - Insider Monkey
Why GoodRx Holdings (GDRX) Stock is Moving Today - GuruFocus.com
Why GoodRx Holdings Stock Was Sinking This Week - The Motley Fool
GoodRx Holdings Inc (GDRX) Q3 2024 Earnings Call Highlights: Str - GuruFocus.com
GoodRx Holdings Inc (GDRX) Q3 2024 Earnings Call Highlights: Strong Financial Performance ... By GuruFocus - Investing.com Canada
GoodRx Holdings Inc (GDRX) Q3 2024 Earnings Call Highlights: Strong Financial Performance ... - Yahoo Finance
GoodRx Holdings Reports Strong Q3 2024 Performance - TipRanks
GoodRx (GDRX) Q3 2024 Earnings Call Transcript - Yahoo Finance
GoodRx (NASDAQ:GDRX) Shares Down 13.9%Here's What Happened - MarketBeat
GoodRx Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
GoodRx Reports Third Quarter 2024 Results - BioSpace
GoodRx (GDRX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
GoodRx Holdings, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year 2024 - Marketscreener.com
GoodRx Q3 revenue misses estimates, lowers full-year outlook By Investing.com - Investing.com Canada
GoodRx Q3 revenue misses estimates, lowers full-year outlook - Investing.com
GoodRx Holdings, Inc. (GDRX) Misses Q3 EPS by 1c ; Offers Guidance - StreetInsider.com
GoodRx (GDRX) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates - MSN
GoodRx accused of conspiring with PBMs over reimbursement fees - Seeking Alpha
GoodRx Holdings Inc (GDRX) Q3 2024 Earnings Report Preview: What to Expect - GuruFocus.com
GoodRx, PBMs Hit by Price Fixing Lawsuits - AJMC.com Managed Markets Network
GoodRx Holdings, Inc. (NASDAQ:GDRX) Shares Purchased by Raymond James & Associates - MarketBeat
Vanguard Group Inc's Strategic Reduction in GoodRx Holdings Inc - GuruFocus.com
GoodRx, PBMs accused of suppressing reimbursements to independent pharmacies - Reuters
GoodRx to Participate in Upcoming Investor Conferences - StockTitan
GoodRx Holdings, Inc. (NASDAQ:GDRX) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
GoodRx Holdings, Inc. (NASDAQ:GDRX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
How To Trade (GDRX) - Stock Traders Daily
GoodRx Unveils New E-commerce Platform, Launches with Opill® - Quantisnow
GoodRx Unveils New E-commerce Platform, Launches with Opill® – Company Announcement - Financial Times
Assenagon Asset Management S.A. Decreases Stake in GoodRx Holdings, Inc. (NASDAQ:GDRX) - MarketBeat
GoodRx (GDRX) Scheduled to Post Quarterly Earnings on Thursday - MarketBeat
Goodrx Holdings Inc Stock (GDRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.88%
1.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):